New possibilities for prostate cancer treatment

Researchers have identified a sub-group of cells that could contribute to prostate cancer recurrence, a disease which claims more than 3,000 lives a year in Australia.

The newly identified cells are potential targets for future treatments as they are present early in disease development. There’s now a possibility of therapy before the cancer reaches the aggressive, incurable stage.

Prostate cancer is the most common form of cancer in men, with around 20,000 new cases diagnosed each year in Australia.

Read more at Monash University